Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer by Signorile, Pietro G et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Journal of Experimental & Clinical 
Cancer Research
Open Access Research
Ectopic endometrium in human foetuses is a common event and 
sustains the theory of müllerianosis in the pathogenesis of 
endometriosis, a disease that predisposes to cancer
Pietro G Signorile*1, Feliciano Baldi2, Rossana Bussani3, 
Mariarosaria D'Armiento4, Maria De Falco5 and Alfonso Baldi*1,2
Address: 1Fondazione Italiana Endometriosi, Rome, Italy, 2Dept Biochemistry, Sect Pathology, Second University of Naples, Naples, Italy, 3Dept. 
of Pathology, University of Trieste, Trieste, Italy, 4Dept. Scienze Biomorfologiche, University of Naples "Federico II", Naples, Italy and 5Dept 
Evolutive and Comparative Biology, University of Naples "Federico II", Naples, Italy
Email: Pietro G Signorile* - aie@endometriosi.it; Feliciano Baldi - felicianobaldi@tiscali.it; Rossana Bussani - bussani@univ.trieste.it; 
Mariarosaria D'Armiento - maria.darmiento@unina.it; Maria De Falco - madefalco@unina.it; Alfonso Baldi* - alfonsobaldi@tiscali.it
* Corresponding authors    
Abstract
Background: Endometriosis is a gynecological disease defined by the histological presence of
endometrial glands and stroma outside the uterine cavity. Women with endometriosis have an
increased risk of different types of malignancies, especially ovarian cancer and non-Hodgkin's
lymphoma. Though there are several theories, researchers remain unsure as to the definitive cause
of endometriosis. Our objective was to test the validity of the theory of müllerianosis for
endometriosis, that is the misplacing of primitive endometrial tissue along the migratory pathway
of foetal organogenesis
Methods: We have collected at autopsy 36 human female foetuses at different gestational age. We
have performed a morphological and immunohistochemical study (expression of oestrogen
receptor and CA125) on the pelvic organs of the 36 foetuses included en-block and totally
analyzed.
Results: In 4 out of 36 foetuses we found presence of misplaced endometrium in five different
ectopic sites: in the recto-vaginal septum, in the proximity of the Douglas pouch, in the
mesenchimal tissue close to the posterior wall of the uterus, in the rectal tube at the level of
muscularis propria, and in the wall of the uterus. All these sites are common location of
endometriosis in women.
Conclusion: We propose that a cause of endometriosis is the dislocation of primitive endometrial
tissue outside the uterine cavity during organogenesis.
Background
Endometriosis is a gynecological disease defined by the
histological presence of endometrial glands and stroma
outside the uterine cavity, most commonly implanted
over visceral and peritoneal surfaces within the female
pelvis [1,2]. The prevalence of endometriosis in the gen-
eral female population is 6–10%; in women with pain,
infertility or both, the frequency increases to 35–60% [3].
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Deep infiltrating endometriosis is a particular form of
endometriosis associated with pelvic pain symptoms,
located under the peritoneal surface [4,5]. Though there
are several theories, researchers remain unsure as to the
definitive cause of endometriosis. The most commonly
accepted mechanism for the development of peritoneal
endometriotic lesions is the Sampson's theory claiming
the adhesion and growth of endometrial fragments depos-
ited into the peritoneal cavity via retrograde menstruation
[4]. On the other hand, the coelomic metaplasia theory
claims that formation of deep endometriosis is caused by
metaplasia of the original coelomic membrane, perhaps
induced by environmental factors [6-8]. A different theory
postulates that endometriosis is caused by little defects of
embryogenesis [9,10]. Indeed, during the embryonic
stage, the primitive cells migrate and undergo differentia-
tion to form the pelvic organs. In particular, the Müllerian
ducts give rise to the female reproductive tract, including
the Fallopian tubes, uterus, cervix, and anterior vagina.
This organogenesis is controlled and directed by a sophis-
ticated, but still incompletely understood, fetal system
including the regulation of the anti-Müllerian hormone
signalling pathway [11]. It has been speculated that aber-
rant differentiation or migration of the Müllerian ducts
could cause spreading of cells or tracts of cells in the
migratory pathway of foetal organogenesis across the pos-
terior pelvic floor and this could conveniently explain the
observation that endometriosis is most commonly and
predictably found in the cul-de-sac, utero-sacral liga-
ments, and medial broad ligaments, although location
anywhere might be possible [12]. This theory of develop-
mentally misplaced endometrial tissue is called mülleria-
nosis [13]. Other theories for the genesis of endometriosis
include different mechanisms such as hematogenous
metastasis, genetic predisposition or altered cellular
immunity [1,2]. Nevertheless, all these theories remain
speculative and no definitive evidences have been pro-
duced to demonstrate them. We speculated that, if the
basis of endometriosis is an alteration during organogen-
esis, it would be possible to see ectopic endometrial tissue
mislocated outside the uterine cavity of human female
foetuses, possibly with a similar frequency found for
endometriosis in the general population. Therefore, we
decided to investigate the anatomy of the pelvic organs of
a group of human female foetuses, collected at autopsy.
Methods
We collected at autopsy 36 human female fetuses at differ-
ent gestational ages, that did not displayed any visible
alteration of the pelvic organs. The characteristics of the
fetuses are depicted in Table 1. Pelvic organs were col-
lected en-block, fixed in paraphormaldeyde and included
in paraffin. We performed histological analysis of the pel-
vic organs for each fetus, using Hematoxylin/Eosin and
Hematoxylin/Van Gieson staining. For immunohisto-
chemistry 5–7 μm specimen sections embedded in paraf-
fin, were cut, mounted on glass and dried overnight at
37°C. All sections were then deparaffinized in xylene,
rehydrated through a graded alcohol series and washed in
phosphate-buffered saline (PBS). PBS was used for all
subsequent washes and for antiserum dilution. Tissue sec-
tions were quenched sequentially in 3% hydrogen perox-
ide in aqueous solution and blocked with PBS-6% non-fat
dry milk (Biorad, Hercules, CA, U.S.A.) for 1 h at room
temperature. Slides were then incubated at 4°C overnight
at 1:100 dilution with the following antibodies: the affin-
ity-purified rabbit antibody ERα for the oestrogen recep-
tor (Santa Cruz, Santa Cruz, CA, USA; cat. # sc-542) and
the mouse monoclonal antibody M11 for CA125(Dako
Laboratories, Carpinteria, CA, USA). After three washes in
PBS to remove the excess of antiserum, the slides were
incubated with diluted goat anti-rabbit or anti-mouse
biotinylated antibodies (Vector Laboratories, Burlingame,
CA, U.S.A.) at 1:200 dilution in PBS-3% non-fat dry milk
(Biorad) for 1 h. All the slides were then processed by the
ABC method (Vector Laboratories) for 30 min at room
temperature. Diaminobenzidine (Vector Laboratories)
was used as the final chromogen and haematoxylin was
used as the nuclear counterstaining. Negative controls for
each tissue section were prepared by leaving out the pri-
mary antiserum. Positive controls constituted of tumour
tissues expressing either the oestrogen receptor or CA125,
were run at the same time. All samples were processed
under the same conditions.
Experiments were performed in compliance with the Hel-
sinki Declaration and the protocols were approved by the
ethics committee of the Fondazione Italiana Endometri-
osi.
Results
In order to analyze the pelvic organs in their entirety, four
sections were taken every 150 microns and stained for his-
tology and for immunohistochemistry, as described in the
method section. We have chosen, for immunohistochem-
isitry, CA125 and the oestrogen receptor, two well defined
marker of epithelium of the female reproductive tract
[1,14]. None of the selected cases displayed macroscopi-
cal or microscopical defects of the genital system. Indeed,
we found in four foetuses (11% of cases), the presence of
organoid structures outside the uterine cavity, clearly
resembling the structure of the primitive endometrium
and expressing both CA125 and oestrogen receptor. These
structures were mislocated outside the uterine cavity and
could not be ascribed to any normal anatomical forma-
tion. In particular, the locations of these endometrial
structures were: in the recto-vaginal septum, in the prox-
imity of the Douglas pouch, in the mesenchimal tissue
close to the posterior wall of the uterus, in the rectal tube
at the level of muscularis propria, and in the wall of theJournal of Experimental & Clinical Cancer Research 2009, 28:49 http://www.jeccr.com/content/28/1/49
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uterus. To note, these anatomical sites are common loca-
tion for endometriosis in women [15]. The exact anatom-
ical distributions and the histological appearances of
these epithelial structures are depicted in detail in figure 1.
We conclude that these structures must be ascribed to dif-
ferentiated endometrial tissue, misplaced outside the uter-
ine cavity during the earlier steps of organogenesis. It is
possible to suppose that this ectopic endometrium would
remain quiescent and, therefore, undetectable until
puberty, when different stimuli, and among them the hor-
monal inputs, would cause its re-growth (as it is the case
for the eutopic endometrium) and, consequently, the
onset of the symptoms of endometriosis.
Discussion
Despite the fact that Sampson's theory of retrograde men-
struation/transplantation is still the most popular and
accepted pathogenetic mechanism of endometriosis, sev-
eral clinical and experimental evidence seems to contrast
this hypothesis. There is, for example, no evidence in vivo
or in vitro that endometrial cells present in the peritoneal
fluid during menstruation can attach to and invade the
peritoneal surface [16]. Furthermore, it has been shown
that endometrial cells are not commonly present in peri-
toneal fluid [16-18]. Additionally, the fact that 90% of
women have retrograde flow but less than 15% of women
develop endometriosis and the presence of the disease in
early puberty, further contrast the validity of the theory
[18]. Finally, this theory fails to explain the presence of
endometriosis in such remote areas as the lungs, skin,
lymph nodes, breasts [1,2]. Interestingly enough, there are
some studies showing higher prevalence of endometriosis
in patients with Müllerian anomalies [19]; moreover, the
existence of choristoma composed of müllerian rests,
named müllerianosis, has been postulated [13]. In recent
years, several evidence suggested that exposure to environ-
Table 1: Characteristics of the foetuses enrolled in this study
N° Gestational age Cause of death Presence of ectopic endometrium
1 18 weeks Voluntary abortion Yes
2 24 weeks Placental pathology Yes
3 25 weeks Placental pathology Yes
4 16 weeks Voluntary abortion Yes
5 23 weeks Placental pathology No
6 15 weeks Voluntary abortion No
7 20 weeks Voluntary abortion No
8 newborn Primary atypical pneumonia No
9 newborn Acute interstitial pneumonitis No
10 16 weeks Voluntary abortion No
11 23 weeks Placental pathology No
12 14 weeks Placental pathology No
13 21 weeks Voluntary abortion No
14 20 weeks Voluntary abortion No
15 20 weeks Voluntary abortion No
16 18 weeks Voluntary abortion No
17 19 weeks Voluntary abortion No
18 16 weeks Voluntary abortion No
19 23 weeks Placental pathology No
20 25 weeks Placental pathology No
21 newborn Acute interstitial pneumonitis No
22 newborn Primary atypical pneumonia No
23 20 weeks Voluntary abortion No
24 19 weeks Voluntary abortion No
25 newborn Cardiac malformation No
26 newborn Cardiac malformation No
27 20 weeks Voluntary abortion No
28 23 weeks Placental pathology No
29 19 weeks Voluntary abortion No
30 newborn Cardiac malformation No
31 newborn Cardiac malformation No
32 19 weeks Voluntary abortion No
33 newborn Acute interstitial pneumonitis No
34 20 weeks Voluntary abortion No
35 newborn Cardiac malformation No
36 21 weeks Placental pathology NoJournal of Experimental & Clinical Cancer Research 2009, 28:49 http://www.jeccr.com/content/28/1/49
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mental toxicants possessing estrogenic activity, the so-
called endocrine disruptors, resulted in endometriosis
[20]. Although the epidemiological evidences are not con-
clusive to date, animal and experimental investigations
have provided a basis for the proposed association
between estrogenic contaminants exposure and endome-
triosis [21]. Nevertheless, the mechanism(s) underlying
this potential association are poorly understood. The
proper function of the normal human endometrium
relies on well organized cell-cell interactions regulated
locally by cytokines and growth factors under the direc-
tion of steroid hormones. The onset and progression of
the disease processes of endometriosis may result from
disruptions of this well balanced cellular equilibrium,
that would cause the interruption of some organizational
events associated with development of the neonatal uter-
Histological and immunohistochemical appearance of ectopic endometrium in four female human foetuses Figure 1
Histological and immunohistochemical appearance of ectopic endometrium in four female human foetuses. 
Panel A: A 25 weeks foetus showing an endometrial structure in the recto-vaginal septum; in the inset named A', the immuno-
histochemical expression of CA-125 of this structure at higher magnification is depicted. Panel B: A 24 weeks foetus showing 
an endometrial structure in the proximity of the Douglas poutch; in the inset named B', the immunohistochemical expression 
of oestrogen receptor of this structure at higher magnification is depicted. Panel C: A 18 weeks foetus showing an endometrial 
structure in the rectal tube at the level of muscularis propria; in the inset named C', the immunohistochemical expression of 
CA-125 of this structure at higher magnification is depicted. Note that the epithelium of the rectum is negative for CA-125. 
Panel D: A 16 weeks foetus showing an endometrial structure in the mesenchimal tissue close to the posterior wall of the 
uterus; in the inset named D', the immunohistochemical expression of CA-125 of this structure at higher magnification is 
depicted. Note that in the wall of the primitive miometrium is present a little group of endometrial cells positive for CA-125 
(indicated by an asterisk), that could represent a primitive nest of adenomyosis. Abbreviations used: an (anus); co (coccyx); dp 
(Douglas' pouch); re (rectum); rvs (recto-vaginal septum); sc (spinal column); ut (uterus); bl (bladder).
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ine wall [21]. To the best of our knowledge, this observa-
tion is the first direct evidence in human female foetuses
of the presence of ectopic endometrium outside the uter-
ine cavity. Our data sustain the müllerianosis hypothesis
of an embryological origin for endometriosis, suggesting
alterations in the fine tuning of female genital structures
organogenesis, possibly caused by environmental toxi-
cants. Interestingly, the percentage of foetuses analyzed in
our study, that displayed the presence of ectopic
endometrium is very similar to the prevalence of women
suffering for this disease in the general population [1-3].
This further suggests a strict link between embryological
abnormalities and onset of the disease, even if the number
of foetuses analyzed is too small in order to reach defini-
tive conclusions. Further studies are urgently required in
order to better define the molecular mechanisms underly-
ing this phenomenon. In particular, ad hoc in vitro and in
vivo models should be set up to analyze the effects on cell
homeostasis and on the morphogenesis of the female gen-
ital system of different endocrine disruptors. Considering
that, based on epidemiological studies, women with
endometriosis have an increased risk of different types of
malignancies, especially ovarian cancer and non-Hodg-
kin's lymphoma [1], the implications of these findings
could be very important also in the oncology field.
Conclusion
The clinical and therapeutic implications of this observa-
tion are straightforward. Endometriosis could not be
regarded as a recurrent disease, therefore surgery, if com-
plete can be considered curative and it would be not justi-
fied post-operative hormonal treatments. Nevertheless, it
must be underlined the fact that other pathogenetic mech-
anisms for the genesis of endometriosis can not be com-
pletely ruled out by these observation, even if, to date,
there are no direct evidence of their validity.
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